The present invention relates to the compound (2R 2 R) bis(((((tetrahydro 2H pyran 4 yl)oxy)carbonyl)oxy)methyl) 1 1 adipoylbis(pyrrolidine 2 carboxylate) pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial including amyloidosis Alzheimer s disease type 2 diabetes mellitus and osteoarthritis.